Results 91 to 100 of about 94,588 (272)
Acta Ophthalmologica, Volume 104, Issue 3, Page 296-304, May 2026.Abstract Purpose To evaluate visual, anatomical and safety outcomes of aflibercept 8 mg in previously treated patients with neovascular age‐related macular degeneration (nAMD). Methods This retrospective study included nAMD patients switched to aflibercept 8 mg from prior anti‐VEGF therapies at Sahlgrenska University Hospital between February 2024 and ...
Imadeddin Abu Ishkheidem +5 more
wiley +1 more source
British Journal of Ophthalmology, 2018 Click here to listen to the Podcast Background/aims To compare the efficacy of combined intravitreal injection of bevacizumab and a Rho-kinase inhibitor, fasudil (intravitreal bevacizumab (IVB)/intravitreal fasudil (IVF)), with IVB alone for centre ...
H. Ahmadieh +8 more
semanticscholar +1 more source
Intravitreal Bevacizumab for Traumatic Choroidal Rupture
Optometry and Vision Science, 2015 ABSTRACT Purpose To report a case of visual loss associated with traumatic choroidal rupture after blunt ocular trauma that was successfully treated with an early intravitreal bevacizumab injection despite the absence of choroidal neovascularization (CNV).
Min, Kim +4 more
openaire +3 more sources
Neovascular age‐related macular degeneration without drusen
Acta Ophthalmologica, Volume 104, Issue 3, Page e300-e311, May 2026.Abstract Purpose To describe the clinical characteristics and 1‐year follow‐up of patients with neovascular AMD (nAMD) without drusen in either eye. Methods This is a multicentre retrospective cohort study in three tertiary referral centres in The Netherlands. We included patients of 55 years or older with nAMD in one or both eyes, without the presence
Marc J. Sirks +9 more
wiley +1 more source
Biopharmaceuticals for Cancer Treatment: An Update
Cancer Medicine, Volume 15, Issue 4, April 2026.ABSTRACT Cancer is one of the most debilitating diseases, causing profound physical and psychological impacts on patients. The global number of cancer patients has been steadily rising over the last few decades. The development of effective cancer therapies remains the primary focus in life science research, requiring a precise understanding of ...
Anupom Deb Nath +6 more
wiley +1 more source
Investigative Ophthalmology and Visual Science, 2017 Purpose To determine the intravitreal pharmacokinetic properties and to study the systemic biodistribution characteristics of I-124-labeled bevacizumab, ranibizumab, and aflibercept with positron emission tomography-computed tomography (PET/CT) imaging ...
J. Christoforidis +6 more
semanticscholar +1 more source
Intraocular Metastasis: Differential Diagnosis and Management
Clinical &Experimental Ophthalmology, Volume 54, Issue 3, Page 382-397, April 2026.ABSTRACT Intraocular metastases represent the most common type of malignant intraocular tumour in adults. These commonly affect the choroid but can also involve the iris, ciliary body, retina, vitreous, optic disc or lens. Breast and lung cancer are the most common origins of intraocular metastases.
Genovefa Μachairoudia +3 more
wiley +1 more source
Delta Journal of Ophthalmology, 2017 Purpose The aim of this study was to investigate the effect of posterior sub-Tenon’s triamcinolone acetonide injection (PSTI) in conjunction with intravitreal bevacizumab for the treatment of persistent diabetic macular edema (DME).
Mona M Aly, Abd Elmagid M Tag Eldin
doaj +1 more source
Retina, 2017 Purpose: The aim of this study was to investigate the changes in plasma vascular endothelial growth factor (VEGF) level depending on the severity of diabetic retinopathy (DR) or diabetic macular edema (DME) and after intravitreal injection of bevacizumab,
Takao Hirano +4 more
semanticscholar +1 more source
Intravitreal bevacizumab for the treatment of choroidal metastasis
Acta Ophthalmologica, 2013 open
Min, Kim +4 more
openaire +3 more sources